Literature DB >> 32624197

Structural Biology of HIV Integrase Strand Transfer Inhibitors.

Ilona K Jóźwik1, Dario O Passos1, Dmitry Lyumkis2.   

Abstract

Integrase (IN) strand transfer inhibitors (INSTIs) are recent compounds in the antiretroviral arsenal used against HIV. INSTIs work by blocking retroviral integration; an essential step in the viral lifecycle that is catalyzed by the virally encoded IN protein within a nucleoprotein assembly called an intasome. Recent structures of lentiviral intasomes from simian immunodeficiency virus (SIV) and HIV have clarified the INSTI binding modes within the intasome active sites and helped elucidate an important mechanism of viral resistance. The structures provide an accurate depiction of interactions of intasomes and INSTIs to be leveraged for structure-based drug design. Here, we review these recent structural findings and contrast with earlier studies on prototype foamy virus intasomes. We also present and discuss examples of the latest chemical compounds that show promising inhibitory potential as INSTI candidates.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIV; antiretroviral therapy; drug resistance; integrase; structure-based drug design

Year:  2020        PMID: 32624197     DOI: 10.1016/j.tips.2020.06.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  8 in total

1.  Retroviral integrase: Structure, mechanism, and inhibition.

Authors:  Dario Oliveira Passos; Min Li; Robert Craigie; Dmitry Lyumkis
Journal:  Enzymes       Date:  2021-08-23

2.  High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.

Authors:  Emmanuel Ndashimye; Yue Li; Paul S Reyes; Mariano Avino; Abayomi S Olabode; Cissy M Kityo; Fred Kyeyune; Immaculate Nankya; Miguel E Quiñones-Mateu; Stephen D Barr; Eric J Arts
Journal:  J Antimicrob Chemother       Date:  2021-10-11       Impact factor: 5.758

3.  Long Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes.

Authors:  Kirsten L White; Nathan Osman; Ernesto Cuadra-Foy; Bluma G Brenner; Devleena Shivakumar; Federico Campigotto; Manuel Tsiang; Philip A Morganelli; Nikolai Novikov; Scott E Lazerwith; Haolun Jin; Anita Niedziela-Majka
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

Review 4.  Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs.

Authors:  Steven J Smith; Xue Zhi Zhao; Dario Oliveira Passos; Dmitry Lyumkis; Terrence R Burke; Stephen H Hughes
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

Review 5.  The C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?

Authors:  Cecilia Rocchi; Patrice Gouet; Vincent Parissi; Francesca Fiorini
Journal:  Viruses       Date:  2022-06-27       Impact factor: 5.818

6.  Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; Africa Holguín
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064

Review 7.  Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis.

Authors:  Jennifer L Elliott; Sebla B Kutluay
Journal:  Viruses       Date:  2020-09-09       Impact factor: 5.048

Review 8.  Clonal Expansion of Infected CD4+ T Cells in People Living with HIV.

Authors:  John M Coffin; Stephen H Hughes
Journal:  Viruses       Date:  2021-10-15       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.